Huang, L., Xu, Y., Liu, N., Chen, H., Wu, Z., Li, Q., . . . Lai, Z. Lenvatinib versus bevacizumab when combined with PD-1/L1 inhibitor and hepatic arterial infusion chemotherapy in unresectable hepatocellular carcinoma. Frontiers Media S.A.
Chicago Style (17th ed.) CitationHuang, Lichang, et al. Lenvatinib Versus Bevacizumab When Combined with PD-1/L1 Inhibitor and Hepatic Arterial Infusion Chemotherapy in Unresectable Hepatocellular Carcinoma. Frontiers Media S.A.
MLA (9th ed.) CitationHuang, Lichang, et al. Lenvatinib Versus Bevacizumab When Combined with PD-1/L1 Inhibitor and Hepatic Arterial Infusion Chemotherapy in Unresectable Hepatocellular Carcinoma. Frontiers Media S.A.
Warning: These citations may not always be 100% accurate.